|
Volumn 185, Issue 1, 2011, Pages 66-
|
Editorial comment
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
VASCULOTROPIN INHIBITOR;
BRAIN METASTASIS;
CANCER SURGERY;
CANCER SURVIVAL;
CYTOREDUCTIVE SURGERY;
HUMAN;
KIDNEY CARCINOMA;
NEPHRECTOMY;
NOTE;
OVERALL SURVIVAL;
PATIENT SELECTION;
PRIORITY JOURNAL;
RETROSPECTIVE STUDY;
TREATMENT OUTCOME;
ANTINEOPLASTIC AGENTS;
CARCINOMA, RENAL CELL;
HUMANS;
KIDNEY NEOPLASMS;
MOLECULAR TARGETED THERAPY;
NEPHRECTOMY;
SURVIVAL RATE;
VASCULAR ENDOTHELIAL GROWTH FACTORS;
|
EID: 78649992792
PISSN: 00225347
EISSN: None
Source Type: Journal
DOI: 10.1016/j.juro.2010.09.138 Document Type: Note |
Times cited : (4)
|
References (3)
|